This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
| - | Shown here is the interaction between paclitaxel and the protein via <scene name='Sandbox_reserved_394/Hydrogen_bonds/ | + | Shown here is the interaction between paclitaxel and the protein via <scene name='Sandbox_reserved_394/Hydrogen_bonds/4'>hydrogen bonding</scene>. The hydrogen bond is formed between an oxygen (red) from the sulfoxone portion of the drug to an "N-H" group (grey) of a glycine amino acid. |
Shown here is the <scene name='Sandbox_reserved_394/Hydrophobic_bonding/3'>hydrophobic bonding</scene> formed between the protein (grey) and a hydrophobic portion of paclitaxel (blue). | Shown here is the <scene name='Sandbox_reserved_394/Hydrophobic_bonding/3'>hydrophobic bonding</scene> formed between the protein (grey) and a hydrophobic portion of paclitaxel (blue). | ||
</StructureSection> | </StructureSection> | ||
Revision as of 17:57, 19 September 2012
== Paclitaxel in Apoptosis ==
| |||||||||||
